Peter Milner is the Chairman and CEO of Renexxion, where they have led the company for over eight years with a focus on advancing sinus health through innovative medical device solutions. With extensive experience in the health sector, Peter previously held high-level positions including CEO at HEART METABOLICS LTD and Chief Medical Officer at Retrotope Inc. Peter's academic foundation includes a BSc (Hons) MB ChB from the University of Liverpool and a Cardiology Fellowship at the University of Virginia. Their commitment to scientific rigor and entrepreneurship has translated into numerous successes in drug discovery and biotechnology.
This person is not in the org chart
This person is not in any teams
This person is not in any offices